FP
Fennec Pharmaceuticals Inc
🇺🇸XNAS.FENCUnited StatesHealthcare
$10.55USDdown -0.07 (-0.66%)ClosedDelayed11:25 PM
Price$10.55-0.07 (-0.66%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CA31447P1009
- CUSIP
- 00686R408
Company
- Employees
- 35
- Headquarters
- Research Triangle Park, United States
- Website
- https://www.fennecpharma.com
- CEO
- Mr. Jeffrey S. Hackman
Market
- Shares outstanding
- 35.1M
- Market cap
- $369.96M
Highlights
- Market cap
- $372.41M
- EPS LTM
- -$0.09calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -113.80calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $59.22M+77.83%up year on year
- Net income
- -$3.25M+72.99%up year on year
- Gross margin
- 93.73%+4.27%up year on year
- Free cash flow
- -$2.04M+82.54%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.